Trials / Completed
CompletedNCT03734315
Routine Application of Ostenil® in Patients with Gonarthrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 115 (actual)
- Sponsor
- TRB Chemedica AG · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
PMCF study to observe the routine application of Ostenil® in the treatment of pain and restricted mobility in degenerative and traumatic changes of the knee joint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ostenil® | Ostenil® is a CE-certified viscoelastic solution for injection into the joint cavity, containing 1.0 % sodium hyaluronate from fermentation. |
Timeline
- Start date
- 2019-01-08
- Primary completion
- 2023-01-12
- Completion
- 2023-01-12
- First posted
- 2018-11-07
- Last updated
- 2024-10-09
Locations
6 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03734315. Inclusion in this directory is not an endorsement.